Senior Clinical Scientist, Data Review & Strategy

Deciphera Pharmaceuticals, Inc.; United States; Remote; USD 120,000 - 180,000; Full time

Job summary

Deciphera Pharmaceuticals, Inc. is seeking a senior clinical data professional to lead data reviews, ensure quality and patient safety, and resolve data-related issues across study teams within oncology, neurology, or rare disease programs.

You will collaborate with Medical Directors and cross-functional teams to prepare clinical data for protocols, investigator brochures, and regulatory documents, and present findings at investigator meetings and study committees.

Qualifications

• PhD or equivalent with 2+ years of relevant experience, or bachelor's/master's with 5+ years of post-graduate pharmaceutical experience.
• Hands-on experience reviewing, analyzing, and interpreting clinical trial data.
• Oncology, neurology, or rare disease experience preferred.

Responsibilities

• Lead clinical data review to support data quality, interpretation, and patient safety.
• Identify and escalate clinically relevant findings and resolve data-related issues with study teams.
• Contribute to clinical documents including protocols, investigator brochures, and regulatory materials.
• Partner with Medical Directors and cross-functional study teams across Clinical Operations, Data Management, Biostatistics, and Regulatory.
• Prepare and present clinical data and scientific information for investigator meetings, advisory boards, and study committees.

Skills

Clinical trial data analysis

Therapeutic area experience (oncology/

Cross-functional collaboration

Education

PhD or equivalent or BSc/MSc in life sciences

Job description

Deciphera Pharmaceuticals, Inc. is seeking a senior clinical data professional to lead data reviews, ensure quality and patient safety, and resolve data-related issues across study teams within oncology, neurology, or rare disease programs.

You will collaborate with Medical Directors and cross-functional teams to prepare clinical data for protocols, investigator brochures, and regulatory documents, and present findings at investigator meetings and study committees.